Document is current
Any future updates will be listed below
-
Authors
Querques, Irma https://orcid.org/0000-0003-1113-2773
Mades, Andreas
Zuliani, Cecilia https://orcid.org/0000-0001-6026-7207
Miskey, Csaba https://orcid.org/0000-0002-7566-9556
Alb, Miriam https://orcid.org/0000-0001-6454-9906
Grueso, Esther
Machwirth, Markus
Rausch, Tobias https://orcid.org/0000-0001-5773-5620
Einsele, Hermann
Ivics, Zoltán https://orcid.org/0000-0002-7803-6658
Hudecek, Michael https://orcid.org/0000-0002-2280-2202
Barabas, Orsolya https://orcid.org/0000-0002-2873-5872
-
Funding
Funding for this research was provided by:
European Molecular Biology Laboratory
EMBL International PhD Programme
European Molecular Biology Laboratory
Paul Ehrlich Institute
Paul Ehrlich Institute
European Molecular Biology Laboratory
Hessisches Ministerium für Wissenschaft und Kunst (LOEWE)
Paul Ehrlich Institute
Deutsche Krebshilfe (Max Eder Program Award 110313)
Bayerische Akademie der Wissenschaften (Junger Kolleg)
Bayerische Akademie der Wissenschaften (m4 Award in Personalized Medicine)
European Molecular Biology Laboratory
- License Information
-
More Information
Article History
Received: 25 June 2019
Accepted: 13 September 2019
First Online: 4 November 2019
Competing interests
: Z.I. is an inventor on patents concerning the development and use of the <i>Sleeping Beauty</i> technology (proprietor Max-Delbrück-Centrum für Molekulare Medizin; patents US9228180B2 and EP2160461B1), and two patent applications have been filed with the European Patent Office concerning the hsSB transposase (EP17187128 and EP19158066.1).
